Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity

被引:76
|
作者
Pinotti, M
Bertolucci, C
Portaluppi, F
Colognesi, I
Frigato, E
Foà, A
Bernardi, F
机构
[1] Univ Ferrara, Dipartmento Biochim & Biol Mol, I-44100 Ferrara, Italy
[2] Univ Ferrara, Dept Biol, I-44100 Ferrara, Italy
[3] Univ Ferrara, Ctr Neurosci, I-44100 Ferrara, Italy
[4] Univ Ferrara, Dept Med Clin & Sperimentale, I-44100 Ferrara, Italy
关键词
factor VII; TFPI; circadian; feeding schedule; mouse model;
D O I
10.1161/01.ATV.0000153140.13148.e0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Diurnal variations in levels of factor VII ( FVII), FVIII, proteins C and S, antithrombin, plasminogen activator inhibitor- 1, prothrombin fragment F1+2, and D-dimers in healthy humans point to the existence of circadian rhythms of coagulation factors. We sought for temporal fluctuations of tissue factor pathway inhibitor ( TFPI) activity in human and mouse plasma. Methods and Results - TFPI activity showed significant daily variations with highest levels in the morning in healthy men ( + 11%) and in mice at the light-to-dark transition ( + 63%), the beginning of the physically active period. Variations in FVII activity paralleled those in TFPI. In mice, the feeding schedule had a strong impact on these rhythms. Although restricted feeding and fasting shifted the peak of TFPI, the FVII peak disappeared. Investigation of temporal fluctuations in constant darkness indicated the existence of daily rhythms for TFPI and of true circadian rhythms for FVII. Conclusions - For the first time, we report, both in humans and mice, temporal variations in TFPI activity. The coherent variations in FVII and TFPI activity could interplay to maintain the coagulation equilibrium. The chronobiological patterns should be considered to analyze activity levels of these factors. Moreover, the mouse model could be exploited to investigate modifiers of coagulation rhythms potentially associated to morning peaks of cardiovascular events.
引用
收藏
页码:646 / 649
页数:4
相关论文
共 50 条
  • [41] High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor
    Erez, Offer
    Romero, Roberto
    Vaisbuch, Edi
    Kusanovic, Juan Pedro
    Mazaki-Tovi, Shali
    Chaiworapongsa, Tinnakorn
    Gotsch, Francesca
    Fareed, Jawed
    Hoppensteadt, Debra
    Than, Nandor Gabor
    Yoon, Bo Hyun
    Edwin, Sam
    Dong, Zhong
    Espinoza, Jimmy
    Mazor, Moshe
    Hassan, Sonia S.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2010, 23 (01): : 23 - 33
  • [42] Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity
    Caplice, NM
    Mueske, CS
    Kleppe, LS
    Simari, RD
    CIRCULATION, 1998, 98 (11) : 1051 - 1057
  • [43] Impact of serum amyloid a on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells
    Zhao, Yulan
    Zhou, Shuli
    Heng, Chew-Kiat
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (07) : 1645 - 1650
  • [44] Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor
    Hackeng, TM
    Seré, KM
    Tans, G
    Rosing, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (09) : 3106 - 3111
  • [45] Estrogenic regulation of tissue factor and tissue factor pathway inhibitor in platelets
    Jayachandran, M
    Sanzo, A
    Owen, WG
    Miller, VM
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 289 (05): : H1908 - H1916
  • [46] Colocalization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis
    Kaikita, K
    Ogawa, H
    Takeya, M
    Yamabe, H
    Kimura, Y
    Hokamura, Y
    Takahashi, K
    CIRCULATION, 1998, 98 (17) : 520 - 520
  • [47] Expression of tissue factor and tissue factor pathway inhibitor in human macrophages
    Lesnik, P
    Petit, L
    Dachet, C
    Moreau, M
    Chapman, J
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 233 - 234
  • [48] Tissue factor and tissue factor pathway inhibitor in surgically treated NSCLC
    Dworakowska, D
    Kulwas, A
    Lapinski, M
    Tomaszewski, D
    Dworakowski, R
    Skokowski, J
    Zekanowska, E
    Rosc, D
    Czestochowska, E
    LUNG CANCER, 2005, 49 : S279 - S279
  • [49] Soluble tissue factor and tissue factor pathway inhibitor in cardiovascular disease
    Toschi, V.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (03) : 472 - 474
  • [50] The role of tissue factor and tissue factor pathway inhibitor in ovarian cancer
    Abu Saadeh, F.
    Norris, L.
    O'Toole, S.
    Gleeson, N.
    THROMBOSIS RESEARCH, 2011, 127 : S149 - S149